TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · major macro event coming up
ARGX

argenx NV

Healthcare · Biotechnology

856.90$ -2.2% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Income Statement

argenx NV (ARGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 4,153 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ARGX
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
1.5 2.2 3.7 4.6 7.5 15 44 25 78 41 1,078 411 1,226 2,190 4,153
1.0 15 22 45 224 251 197 371 581 29 118 227 451
1.5 2.2 2.7 4.6 7.5 15 44 25 78 41 497 381 1,108 1,963 3,703
6.3 15 13 15 23 33 62 96 221 370 581 663 859 983 1,364
1.9 2.2 2.2 4.2 5.4 7.4 15 26 72 171 246 354 507 745 931
6.2 15 12 18 25 38 71 118 277 519 846 1,102 1,534 1,985 2,648
-4.7 -13 -8.8 -13 -17 -23 -28 -94 -199 -478 -349 -720 -425 -22 1,055
0.0 0.0 0.0 0.0 0.0 0.0 5.7 35 0.1 0.4 1.1 2.2 0.9 2.2 4.1
-4.5 -13 -8.5 -13 -17 -22 -33 -75 -176 -605 -400 -729 -304 85 1,279
0.0 0.0 -0.3 -0.4 -0.2 0.0 0.7 0.9 5.3 3.1 8.5 -20 -9.4 -748 -13
-4.5 -13 -8.5 -13 -17 -22 -34 -76 -181 -608 -408 -710 -295 833 1,292
-4.2 -13 -8.3 -12 -17 -22 -32 -93 -173 -601 -393 -623 -192 105 1,311

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?